Johnson & Johnson Receives FDA Market Authorization in the U.S. for its OTTAVA™ Robotic Surgical System
Go back to Johnson & Johnson Receives FDA Market Authorization in the U.S. for its OTTAVA™ Robotic Surgical System| Johnson & Johnson (NYSE: JNJ) | Delayed: 255.68 -3.68 (1.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $259.36 | 52 Week High | $126.07 | |||
| Open | $257.50 | 52 Week Low | $94.28 | |||
| Day High | $257.75 | P/E | 53.16 | |||
| Day Low | $254.56 | EPS | $4.81 | |||
| Volume | 1,860,108 | |||||



